The Effect of Hydrogen Water in Oral Mucositis in Head and Neck Cancer Patients After Therapy
1 other identifier
interventional
30
1 country
1
Brief Summary
Inpatients or outpatients diagnosed with head and neck cancer who met the inclusion and exclusion criteria were referred to the co-investigator(Dr. Chih-Jen Huang and Dr. Hui-Ching Wang), who then personally explained to each participant, the purpose and conduct of the study, so that they all understood their rights and interests before giving a written consent.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable head-and-neck-cancer
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedStudy Start
First participant enrolled
December 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
ExpectedDecember 27, 2023
May 1, 2023
5 months
June 4, 2023
December 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participants With Treatment-Related Adverse Events as Assessed by CTCAE v5.0,Change From Baseline in Pain Scores on the Brief Pain Inventory-Taiwan Scale at 2 Weeks
weight and height will be combined to report BMI in kg/m\^2
2 weeks
Study Arms (2)
hydrogen water
EXPERIMENTALAt the end of cancer treatment (chemotherapy, radiotherapy, or Chemoradiotherapy), a hydrogen water gargle (dissolved for 12 hours or longer) was administered by the investigator or a researcher every Monday through Friday. The changes in six scales described above were tracked in the experimental and control groups on days 1 (T1), 3 (T2), 7 (T3), and 14 (T4) after the end of treatment.
boiled water
PLACEBO COMPARATORAt the end of cancer treatment (chemotherapy, radiotherapy, or Chemoradiotherapy),boiled water gargle was administered by the investigator or a researcher every Monday through Friday. The changes in six scales described above were tracked in the experimental and control groups on days 1 (T1), 3 (T2), 7 (T3), and 14 (T4) after the end of treatment.
Interventions
To investigate whether the intervention of hydrogen water adjuvant therapy can improve oral mucositis, oral frailty, pain and Quality of Life with head and neck cancer who have received radiation therapy or combined chemotherapy.
Eligibility Criteria
You may qualify if:
- pathological diagnosed with head and neck cancer
- adults over the age of 20
- have normal cognition
- can use Mandarin or Taiwanese to communicate
- received radiation therapy or combined chemotherapy
You may not qualify if:
- Eastern Cooperative Oncology Group (ECOG) performance status 2, 3 and 4
- received oral cancer surgery within two months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Sanmin Dist, 807, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chih-Jen Huang
Kaohsiung Medical University Chung-Ho Memorial Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2023
First Posted
June 22, 2023
Study Start
December 24, 2023
Primary Completion
May 19, 2024
Study Completion (Estimated)
October 31, 2026
Last Updated
December 27, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share